Vaxcyte (PCVX) announced the appointment of Jacks Lee to its Board of Directors. Most recently, Lee was Senior Vice President of Global Manufacturing and Supply at Merck (MRK)
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PCVX:
- Vaxcyte Appoints Jacks Lee to Board of Directors
- Vaxcyte in manufacturing pact with Sutro Biopharma for PCV franchise control
- Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates
- Vaxcyte doses first participants in Phase 2/3 study on VAX-31
- Vaxcyte Doses First Participants in Phase 1/2 Clinical Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Adults